NxStage Medical, Inc. (NXTM)
Q4 2013 Earnings Conference Call
February 27, 2014 9:00 AM ET
Kristen Sheppard – VP, IR
Jeff Burbank – CEO
Matt Towse – CFO
Bill Plovanic – Canaccord Genuity
By Andy Batts:
NxStage Medical (NXTM) is a medical device company in the dialysis therapy market that develops, manufactures and markets innovative products for the treatment of kidney failure, fluid overload and related blood treatments and...
FirstEnergy (NYSE: FE) shares fell 0.59% to reach a new 52-week low of $35.20. FirstEnergy's PEG ratio is 9.44.
AU Optronics (NYSE: AUO) shares reached a new 52-week low of $2.83. AU Optronics' trailing-twelve-month ROE is -5.67%.
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.
You may also be interested in articles related to NxStage Medical (NXTM):